Von der Leyen Survives, But the Storm Clouds Gather: EU Politics in a New Era The recent vote of censure against European Commission President Ursula von der Leyen, though ultimately unsuccessful, has served as a stark reminder of the shifting sands beneath the European Union’s political landscape. While she retained her position, the dynamics revealed … Read more
The Rise of NB.1.8.1: Understanding the New COVID-19 Variant and What’s Next As a seasoned health journalist, I’ve been closely following the evolution of COVID-19. The emergence of new variants is a constant reality, and understanding these changes is crucial. Let’s delve into NB.1.8.1, the latest variant making headlines, and what its spread might mean … Read more
The Bitter Pill of Tariffs: Ireland’s Pharma Dilemma The picturesque town of Westport in County Mayo stands in stark contrast to its grey, factory-dominated skyline. These factories, chiefly producing Botox and other pharmaceuticals, form the economic backbone of Westport. Yet, President Donald Trump’s push for reshoring pharma production casts uncertainty over the 7,000 individuals dependent … Read more
The Return of Champix: A Turning Point for Smoking Cessation The pharmaceutical giant Pfizer recently announced the re-release of Champix, a notable player in the smoking cessation market. Previously withdrawn in 2021 due to nitrosamine levels surpassing safety limits, this drug’s comeback raises important questions about its effectiveness and role in modern healthcare. How Does … Read more
The Power of Simple Lifestyle Changes: Cutting Cancer Risk Recent studies have underscored the profound impact that simple lifestyle choices, such as increased sun exposure, regular exercise, and dietary adjustments, can have on reducing cancer risk. In 2022, researchers from the University of Zurich discovered that a combination of Vitamin D, omega-3 fatty acids, and … Read more
The Science of Timelines: Vaccine Development and Political Accusations The development and announcement of Pfizer’s Covid-19 vaccine have become a focal point of political debate and legal scrutiny. With allegations suggesting that Pfizer delayed positive news until after the 2020 U.S. Presidential election, a thorough investigation remains active, inviting questions about the interplay between science, … Read more
The Ongoing Saga of COVID-19 Vaccines Five years into the COVID-19 pandemic, the race for a universal vaccine continues. The initial vaccines, developed with pioneering ARN messenger technology, have evolved as the virus mutates into new variants. Though the pandemic still poses a risk, the progress made in vaccine development holds promise for future advancements. … Read more
The Rise of Post-Vaccination Syndrome: Understanding the Phenomenon In recent years, reports of adverse effects following vaccinations, particularly the Covid-19 vaccine, have gained attention. A noteworthy aspect of this dynamic is the emergence of ‘post-vaccination syndrome,’ as highlighted in recent studies like those conducted by Yale University. The syndrome manifests through symptoms including brain fog, … Read more
The Uncertain Future of COVID-19 Vaccination for Pregnant Women The recent publication of Pfizer-BioNTech’s phase II and III study results has stirred considerable debate among healthcare professionals and pregnant women worldwide. The comprehensive analysis by Carl Henegham and Tom Jefferson from Oxford’s Centre for Evidence-Based Medicine underscores the complexities in ascertaining the safety of COVID-19 … Read more
The Supreme Court’s Role in Setting Transparency Standards for Vaccine Procurement The Supreme Court of Spain recently admitted a key appeals case challenging the transparency of vaccine procurement agreements against COVID-19. This follows a government refusal to disclose details of contracts, including pricing and terms, with pharmaceutical companies and international bodies. Taken to court by … Read more